Position dérivée des transactions déclarées les plus récentes. Non ajustée des splits ni des conversions de classes d'actions.
| Émetteur | Actions | Source | Dernière tx | Détail |
|---|---|---|---|---|
| PDS Biotechnology Corp | 54 876 | déclaré | 12 janv. 2026 | tx 9+137 373 |
| RIGEL PHARMACEUTICALS INC | 12 625 | déclaré | 26 mai 2026 | tx 11+282 500−2 500 |
| Aclaris Therapeutics, Inc. | 0 | déclaré | 03 janv. 2022 | tx 114+921 527−449 084 |
| Date | Type | Émetteur | Quantité | Prix | Signaux |
|---|---|---|---|---|---|
| 26 mai 2026 | SALE | RIGEL PHARMACEUTICALS INC | 2 500 | 29.17 USD | 10b5-1 |
| 15 mai 2026 | GRANT_AWARD | RIGEL PHARMACEUTICALS INC | 5 750 | 0.00 USD | |
| 12 janv. 2026 | GRANT_AWARD | PDS Biotechnology Corp | 54 876 | 0.00 USD | deriv |
| 11 juin 2025 | GRANT_AWARD | PDS Biotechnology Corp | 22 700 | 0.00 USD | deriv |
| 23 mai 2025 | GRANT_AWARD | RIGEL PHARMACEUTICALS INC | 2 500 | 0.00 USD | |
| 23 mai 2025 | GRANT_AWARD | RIGEL PHARMACEUTICALS INC | 3 000 | 0.00 USD | deriv |
| 24 juin 2024 | GRANT_AWARD | PDS Biotechnology Corp | 9 000 | 0.00 USD | deriv |
| 25 mai 2024 | GRANT_AWARD | RIGEL PHARMACEUTICALS INC | 25 000 | 0.00 USD | |
| 25 mai 2024 | GRANT_AWARD | RIGEL PHARMACEUTICALS INC | 30 000 | 0.00 USD | deriv |
| 14 juil. 2023 | GRANT_AWARD | PDS Biotechnology Corp | 9 000 | 0.00 USD | deriv |
| 26 mai 2023 | GRANT_AWARD | RIGEL PHARMACEUTICALS INC | 25 000 | 0.00 USD | |
| 26 mai 2023 | GRANT_AWARD | RIGEL PHARMACEUTICALS INC | 30 000 | 0.00 USD | deriv |
| 28 juin 2022 | GRANT_AWARD | PDS Biotechnology Corp | 9 000 | 0.00 USD | deriv |
| 20 mai 2022 | GRANT_AWARD | RIGEL PHARMACEUTICALS INC | 18 750 | 0.00 USD | |
| 20 mai 2022 | GRANT_AWARD | RIGEL PHARMACEUTICALS INC | 22 500 | 0.00 USD | deriv |
| 03 janv. 2022 | EXERCISE | Aclaris Therapeutics, Inc. | 3 875 | — | |
| 03 janv. 2022 | EXERCISE | Aclaris Therapeutics, Inc. | 6 638 | — | |
| 03 janv. 2022 | EXERCISE | Aclaris Therapeutics, Inc. | 27 905 | — | |
| 03 janv. 2022 | EXERCISE | Aclaris Therapeutics, Inc. | 7 100 | — | |
| 03 janv. 2022 | EXERCISE | Aclaris Therapeutics, Inc. | 6 638 | 0.00 USD | deriv |
| 03 janv. 2022 | EXERCISE | Aclaris Therapeutics, Inc. | 27 905 | 0.00 USD | deriv |
| 03 janv. 2022 | EXERCISE | Aclaris Therapeutics, Inc. | 7 100 | 0.00 USD | deriv |
| 03 janv. 2022 | EXERCISE | Aclaris Therapeutics, Inc. | 3 875 | 0.00 USD | deriv |
| 16 déc. 2021 | GRANT_AWARD | RIGEL PHARMACEUTICALS INC | 120 000 | 0.00 USD | deriv |
| 11 mars 2021 | GIFT | Aclaris Therapeutics, Inc. | 7 500 | 0.00 USD |